drugset / Trial / NCT05442151
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
NaSingle-groupOpen-labelDiagnostic
Summary
PET / CT examination using \[18F\] FAPI-74 is performed on patients diagnosed with malignant tumor, and the pathological condition is determined by comparing with FDG-PET/CT examination of conventional diagnostic imaging.
Timeline
- Start
- 2022-05-09
- Primary completion
- 2026-03-31
- Completion
- 2026-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FAPI-74 | Diagnostic / imaging agent | — | Other |